Toh et al. have demonstrated that hyperacetylation of histones in esophageal cancer is associated with HDAC 1 overexpression which suggests that HDAC expression might be a marker of such an imbalance between acetylation and deacetylation in the neoplasm [31]. The gene discussed is HDAC9; the disease is esophageal cancer.